Small Airways Disease (SAD) in Severe Asthma as a Novel Endpoint and Distinct Target for Mepolizumab (SASAM Study)
Conditions
- Small Airway Disease
- Asthma
Interventions
- DIAGNOSTIC_TEST: Small airways assessment
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS